MoneyWorks4Me

The revenue zoomed 13.49% to Rs. 1663.22 millions for the quarter ended December 2025 as compared to Rs. 1465.52 millions during the corresponding quarter last year.Good  Net Profit growth of 37.70% reported above the corresponding previous quarter figure of Rs. 207.70 millions to Rs. 286.01 millioins.Operating profit surged to 387.42 millions from the corresponding previous quarter of 326.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1663.22 1465.52 13.49 4837.53 4550.48 6.31 6232.30 5805.50 7.35
Other Income 151.46 89.70 68.85 376.50 293.57 28.25 224.77 344.22 -34.70
PBIDT 387.42 326.34 18.72 1104.78 1041.32 6.09 1239.71 1343.30 -7.71
Interest 2.98 7.28 -59.07 7.39 15.16 -51.25 18.83 14.63 28.71
PBDT 384.44 319.06 20.49 1097.39 1026.16 6.94 1220.88 1328.67 -8.11
Depreciation 37.21 32.24 15.42 108.17 96.72 11.84 128.99 106.25 21.40
PBT 347.23 286.82 21.06 989.22 929.44 6.43 1091.89 1222.42 -10.68
TAX 61.22 79.12 -22.62 226.62 221.71 2.21 268.42 289.38 -7.24
Deferred Tax 1.12 -1.33 -184.21 35.78 34.95 2.37 15.15 34.95 -56.65
PAT 286.01 207.70 37.70 762.60 707.73 7.75 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 23.29 22.27 4.61 22.84 22.88 -0.20 19.89 23.14 -14.03
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..